多囊卵巢综合征诊断与管理临床实践指南的系统综述与质量评价
该研究系统检索MEDLINE、EMBASE和CENTRAL至2020年12月的多囊卵巢综合征(PCOS)循证指南与共识,纳入13部2007至2018年发布的指南,用AGREE II工具评价方法学质量并映射推荐意见。结果显示指南推荐多聚焦代谢病筛查(12/13,92%)和心血管风险评估(10/13,77%),而青少年诊断、生活方式干预、多毛/痤疮治疗、卵巢过度刺激综合征预防、代谢与心血管筛查频率及精神疾病筛查工具等方面推荐不一致。
要点
- PCOS指南推荐多集中于代谢病筛查(12/13,92%)和心血管风险评估(10/13,77%)。
- 精神健康(8/13,62%)和青少年诊断(7/13,54%)是报告最少的领域。
- 利益相关者参与和推荐意见适用性仅2部指南(2/13,15%)表现适当。
核心结论
- 当前PCOS诊断与管理指南在范围和方法学质量上存在差异,可能阻碍证据向临床实践转化。
- 研究识别了存在证据缺口的疾病领域,可指导未来研究和指南更新。
研究设计与样本
- 系统检索MEDLINE、EMBASE和CENTRAL截至2020年12月的PCOS循证指南和共识声明。
- 纳入13部2007至2018年发布的PCOS临床实践指南,双重提取数据并映射推荐至预设疾病领域。
- 使用AGREE II工具评价指南方法学质量。
主要发现
- 指南推荐主要聚焦代谢病筛查与管理(12/13,92%),其次为心血管风险评估(10/13,77%)。
- 精神健康(8/13,62%)和青少年诊断(7/13,54%)是报告最少的领域。
- 大多数指南在范围和目的描述上质量高(12/13,92%),但利益相关者参与和适用性仅2部指南(2/13,15%)适当。
- 推荐不一致涉及青少年PCOS诊断、最佳生活方式干预、多毛和痤疮治疗、降低卵巢过度刺激综合征风险的干预、代谢和心血管疾病的筛查频率与标准、以及PCOS女性精神疾病的最佳筛查工具。
临床怎么用
- 临床医生应意识到PCOS指南在青少年诊断、生活方式干预、多毛/痤疮治疗及代谢心血管筛查频率等方面推荐不一致。
- 应用指南时需关注其方法学质量差异,尤其是利益相关者参与和适用性领域可能不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Clinical practice guidelines (CPGs) are key instruments to implement the practice of evidence-based medicine. We aimed to evaluate the methodological quality and variations in CPGs recommendations on the diagnosis and management of polycystic ovary syndrome (PCOS). EVIDENCE ACQUISITION: We searched MEDLINE, EMBASE, and CENTRAL until December 2020 for all evidence-based CPGs and consensus statements on PCOS. We extracted data in duplicate to map clinical recommendations across prespecified disease domains and assessed CPGs methodological quality of using the Appraisal of Guidelines, Research & Evaluation II tool. EVIDENCE SYNTHESIS: We included 13 PCOS CPGs published between 2007 and 2018. CPGs recommendations were mostly focused on screening for and managing metabolic disease (12/13, 92%), followed by cardiovascular risk assessment (10/13, 77%). Mental health (8/13, 62%) and diagnosis in adolescents (7/13, 54%) were the least reported domains. Most CPGs had a high quality for scope and purpose description (12/13, 92%) while stakeholder's involvement and applicability of recommendations to clinical practice were appropriate in only 2 CPGs (2/13, 15%). We identified inconsistency in recommendations on PCOS diagnosis in adolescents, optimal lifestyle interventions, hirsutism and acne treatments, interventions to reduce the risk of ovarian hyperstimulation syndrome, the frequency and screening criteria for metabolic and cardiovascular disease, and optimal screening tools for mental health illness in women with PCOS. CONCLUSION: Current CPGs on the diagnosis and management of PCOS vary in their scope and methodological quality, which may hinder evidence translation into clinical practice. We identified disease domains with existing evidence gap to guide future research and guideline updates.
引用
- Al Wattar BH, Fisher M, Bevington L, et al. Clinical Practice Guidelines on the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Review and Quality Assessment Study. J Clin Endocrinol Metab. 2021. PMID: 33839790. doi:10.1210/clinem/dgab232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。